EN
登录

数字物理治疗服务平台OneStep获得3600万美元融资,将步态分析确立为第六个生命体征

HLTH: OneStep Secures $36M to Establish Gait Analysis as the Sixth Vital Sign

HIT 等信源发布 2024-10-22 13:22

可切换为仅中文


What You Should Know:

您应该知道:

– OneStep, a provider of smartphone-based motion analysis technology has raised $36M in funding co-led by Team8 and Vintage Investment Partners.

–基于智能手机的运动分析技术提供商OneStep已筹集3600万美元资金,由Team8和Vintage Investment Partners共同牵头。

– The company aims to establish gait analysis – the study of how a person walks – as the sixth vital sign, crucial for understanding and improving overall health.

–该公司旨在建立步态分析(研究一个人如何行走)作为第六个生命体征,对理解和改善整体健康至关重要。

Transforming Smartphones into Clinical Tools

将智能手机转化为临床工具

OneStep’s technology turns smartphones into clinical-grade motion analysis tools, making gait analysis as simple as stepping on a bathroom scale. By capturing and analyzing patient movement data, healthcare providers gain valuable insights into mobility and overall health, enabling timely interventions and improved patient engagement..

OneStep的技术将智能手机转变为临床级的运动分析工具,使步态分析变得像踩浴室秤一样简单。通过捕获和分析患者移动数据,医疗保健提供者可以获得对流动性和整体健康的宝贵见解,从而能够及时干预并提高患者的参与度。。

The Importance of Gait Analysis in an Aging Population

步态分析在人口老龄化中的重要性

As life expectancy increases, so does the prevalence of chronic conditions that affect mobility and gait. Gait analysis can reveal crucial information about the health of various body systems, including nervous, musculoskeletal, and cardiorespiratory functions. Early detection of conditions like falls, Parkinson’s disease, and Alzheimer’s disease through gait analysis can lead to proactive interventions and improved quality of life..

随着预期寿命的增加,影响活动能力和步态的慢性病的患病率也随之增加。步态分析可以揭示有关各种身体系统健康的关键信息,包括神经,肌肉骨骼和心肺功能。通过步态分析及早发现跌倒、帕金森病和阿尔茨海默病等疾病,可以采取积极的干预措施,提高生活质量。

OneStep’s AI-Powered Platform Key Features

OneStep的人工智能平台关键功能

OneStep’s FDA-listed, AI-powered platform offers continuous, real-life monitoring of patient gait and mobility. This provides healthcare providers with actionable, real-time data, enabling them to:

OneStep的FDA上市的人工智能平台提供了对患者步态和活动性的连续实时监测。这为医疗保健提供者提供了可操作的实时数据,使他们能够:

Enhance Patient Outcomes: Improve patient recovery and reduce the risk of falls through early detection and intervention.Improve Decision-Making: Make more informed treatment decisions based on objective gait analysis data.Streamline Documentation: Automate documentation processes and reduce administrative burden.Reduce Costs: Minimize healthcare costs associated with falls and other mobility-related complications.Generate New Revenue: Leverage Remote Therapeutic Monitoring (RTM) capabilities for reimbursement opportunities..

提高患者预后:通过早期发现和干预,改善患者康复并降低跌倒风险。。简化文档编制:自动化文档编制过程并减轻管理负担。降低成本:最大程度地减少与跌倒和其他与活动相关的并发症相关的医疗保健成本。产生新收入:利用远程治疗监测(RTM)功能获得报销机会。

OneStep Expansion Plans

一步式扩展计划

Scale Operations: Expand its reach and impact across the healthcare industry.Further Develop its Technology: Enhance its AI-powered platform and introduce new features and functionalities.Establish Gait Analysis as a Standard: Promote the adoption of gait analysis as a routine part of health monitoring and improvement..

规模经营:扩大其在整个医疗保健行业的影响力。进一步开发其技术:增强其人工智能平台,并引入新功能。将步态分析确立为标准:促进步态分析作为健康监测和改善的常规部分。

“Motion is life, and understanding it is key to advancing health.” said Tomer Shussman, co-founder and CEO of OneStep. “By empowering healthcare providers with real-time insights into how patients move, we’re helping unlock the power of gait – transforming healthcare to be more proactive, precise, and focused on improving quality of life.” .

OneStep联合创始人兼首席执行官托默·舒斯曼(TomerShussman)表示:“运动就是生命,了解运动是增进健康的关键。”